1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow IEV407: new trials by email Literature Review of IEV407 trials Research Report on IEV407
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer IEV407, Fulvestrant, Letrozole - Advanced HR+/HER2- Breast Cancer | Phase 1 | Recruiting | Novartis Pharmaceuticals | 194 | 2026-05-28 | 2026-10-20 |
Canada (1) · France (1) · Italy (1) · Japan (1) · Singapore (1) · South Korea (1) · United States (1)
2025 (1)